Search - tctmd.com

Displaying 1 - 20 of 317

Sort: Relevancy | Date

News Conference News TCT 2025

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

Caitlin E. Cox

October 27, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Conference News TCT 2024

Few Patients Under 65 Get TAVI: Those Who Do Are Especially Sick

Yael L. Maxwell

November 07, 2024

News Conference News TCT 2024

Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI

Michael O'Riordan

November 06, 2024

News Conference News TCT 2024

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

Yael L. Maxwell

November 05, 2024

News Conference News TCT 2024

Vascular Closure via Suture/Plug Combo Reduces Complications: ACCESS-TAVI

Caitlin E. Cox

November 04, 2024

News Conference News TCT 2024

Embolic Protection Benefits Varied by Geography in PROTECTED TAVR

Todd Neale

October 31, 2024

Presentation TCT 2024

TCT 861: CURE-VHD (Comprehensive Unified Regimen for Eliminating Valvular Heart Disease): Using Artificial Intelligence to Identify Patients With Untreated Aortic Stenosis

Presenter: Daniel Mitchell

October 30, 2024

Presentation TCT 2024

TCT 645: Calcified Aortic Valve Disease-related Mortality Trends in the United States Over the Past 3 Decades

Presenter: Zaid Abdulelah

October 30, 2024

Presentation TCT 2024

TCT 804: Impact of Gender and Race on the Outcomes of Transcatheter Aortic Valve Replacement in Peripheral Arterial Disease

Presenter: Junaid Mir

October 30, 2024

Presentation TCT 2024

Can “At Risk” Disease Phenotypes Prioritize Earlier Treatment (EVOLVED)

Presenter: Mark Dweck

October 30, 2024

Presentation TCT 2024

POINT: TAVR Will Reign Supreme!

Presenter: Vinod Thourani

October 30, 2024

Presentation TCT 2024

COUNTERPOINT: The Surgical Standard Will Predominate!

Presenter: Michael Bowdish

October 30, 2024

Presentation TCT 2024

Overview of Clinical Data on TAVR in BAVD – Is an RCT Needed?

Presenter: Yousif Ahmad

October 30, 2024

Presentation TCT 2024

TCT 1505: Trans-Femoral TAVR in an End-Stage Liver Disease Patient With Severe Aortic Regurgitation due to Infective Endocarditis

Presenter: Joshua Zuniga

October 30, 2024

Presentation TCT 2024

CONTROVERSY: Device Selection and Sizing for TAVR in BAVD

Presenter: Didier Tchetche

October 30, 2024

Presentation TCT 2024

TCT 186: Periprocedural Continuation Versus Interruption of Oral Anticoagulation During Transcatheter Aortic-Valve Implantation: Impact on Health-Related Quality of Life

Presenter: Dirk Jan van Ginkel

October 29, 2024

Presentation TCT 2024

TCT 911: Vascular Disease in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: From Incidence to Clinical Outcomes

Presenter: Gijs Broeze

October 29, 2024

Presentation TCT 2024

TCT 644: Burden of Non-Rheumatic Calcific Aortic Valve Disease and Non-Rheumatic Degenerative Mitral Valve Disease in High-Income North America and West Europe From 1990 to 2021

Presenter: Vidit Majmundar

October 29, 2024

Presentation TCT 2024

TCT 640: Temporal Trends in Calcified Aortic Valve Disease-related Mortality in Canada Over the Past 30 Years

Presenter: Zaid Abdulelah

October 29, 2024

Advertisement

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

What’s Going to Be Hot at TCT 2025

Few Patients Under 65 Get TAVI: Those Who Do Are Especially Sick

Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

Vascular Closure via Suture/Plug Combo Reduces Complications: ACCESS-TAVI

Embolic Protection Benefits Varied by Geography in PROTECTED TAVR

TCT 861: CURE-VHD (Comprehensive Unified Regimen for Eliminating Valvular Heart Disease): Using Artificial Intelligence to Identify Patients With Untreated Aortic Stenosis

TCT 645: Calcified Aortic Valve Disease-related Mortality Trends in the United States Over the Past 3 Decades

TCT 804: Impact of Gender and Race on the Outcomes of Transcatheter Aortic Valve Replacement in Peripheral Arterial Disease

Can “At Risk” Disease Phenotypes Prioritize Earlier Treatment (EVOLVED)

POINT: TAVR Will Reign Supreme!

COUNTERPOINT: The Surgical Standard Will Predominate!

Overview of Clinical Data on TAVR in BAVD – Is an RCT Needed?

TCT 1505: Trans-Femoral TAVR in an End-Stage Liver Disease Patient With Severe Aortic Regurgitation due to Infective Endocarditis

CONTROVERSY: Device Selection and Sizing for TAVR in BAVD

TCT 186: Periprocedural Continuation Versus Interruption of Oral Anticoagulation During Transcatheter Aortic-Valve Implantation: Impact on Health-Related Quality of Life

TCT 911: Vascular Disease in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: From Incidence to Clinical Outcomes

TCT 644: Burden of Non-Rheumatic Calcific Aortic Valve Disease and Non-Rheumatic Degenerative Mitral Valve Disease in High-Income North America and West Europe From 1990 to 2021

TCT 640: Temporal Trends in Calcified Aortic Valve Disease-related Mortality in Canada Over the Past 30 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content